Skip to Content
주식/증권 ➡️ 중립

NTRA & Diakonos Partner to Use Signatera in Refractory Melanoma Trial

요약

Natera teams with Diakonos to use Signatera MRD testing in a refractory melanoma immunotherapy trial, tracking ctDNA to gauge response.